Literature DB >> 19509166

Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma.

Chunyu Zhang1, Li Fu, Jianhua Fu, Liang Hu, Hong Yang, Tie-Hua Rong, Yan Li, Haibo Liu, Song-Bin Fu, Yi-Xin Zeng, Xin-Yuan Guan.   

Abstract

PURPOSE: Tumor fibroblasts (TF) have been suggested to play an essential role in the complex process of tumor-stroma interactions and tumorigenesis. The aim of the present study was to investigate the specific role of TF in the esophageal cancer microenvironment. EXPERIMENTAL
DESIGN: An Affymetrix expression microarray was used to compare gene expression profiles between six pairs of TFs and normal fibroblasts from esophageal squamous cell carcinoma (ESCC). Differentially expressed genes were identified, and a subset was evaluated by quantitative real-time PCR and immunohistochemistry.
RESULTS: About 43% (126 of 292) of known deregulated genes in TFs were associated with cell proliferation, extracellular matrix remodeling, and immune response. Up-regulation of fibroblast growth factor receptor 2 (FGFR2), which showed the most significant change, was detected in all six tested TFs compared with their paired normal fibroblasts. A further study found that FGFR2-positive fibroblasts were only observed inside the tumor tissues and not in tumor-surrounding stromal tissues, suggesting that FGFR2 could be used as a TF-specific marker in ESCC. Moreover, the conditioned medium from TFs was found to be able to promote ESCC tumor cell growth, migration, and invasion in vitro.
CONCLUSIONS: Our study provides new candidate genes for the esophageal cancer microenvironment. Based on our results, we hypothesize that FGFR2(+)-TFs might provide cancer cells with a suitable microenvironment via secretion of proteins that could promote cancer development and progression through stimulation of cancer cell proliferation, induction of angiogenesis, inhibition of cell adhesion, enhancement of cell mobility, and promotion of the epithelial-mesenchymal transition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19509166     DOI: 10.1158/1078-0432.CCR-08-2824

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  51 in total

1.  Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.

Authors:  Feiyan Deng; Keming Zhou; Wenli Cui; Dong Liu; Yuqing Ma
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 2.  Stromal cells in tumor microenvironment and breast cancer.

Authors:  Yan Mao; Evan T Keller; David H Garfield; Kunwei Shen; Jianhua Wang
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

3.  RNA editing of SLC22A3 drives early tumor invasion and metastasis in familial esophageal cancer.

Authors:  Li Fu; Yan-Ru Qin; Xiao-Yan Ming; Xian-Bo Zuo; Yu-Wen Diao; Li-Yi Zhang; Jiaoyu Ai; Bei-Lei Liu; Tu-Xiong Huang; Ting-Ting Cao; Bin-Bin Tan; Di Xiang; Chui-Mian Zeng; Jing Gong; Qiangfeng Zhang; Sui-Sui Dong; Juan Chen; Haibo Liu; Jian-Lin Wu; Robert Z Qi; Dan Xie; Li-Dong Wang; Xin-Yuan Guan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

4.  Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells.

Authors:  Zhiyong Liu; Yolanda E Hartman; Jason M Warram; Joseph A Knowles; Larissa Sweeny; Tong Zhou; Eben L Rosenthal
Journal:  Mol Cancer Res       Date:  2011-06-10       Impact factor: 5.852

5.  Cellular changes in the tumor microenvironment of human esophageal squamous cell carcinomas.

Authors:  Jinzhong Liu; Zhenfeng Li; Jing Cui; Gang Xu; Guanglin Cui
Journal:  Tumour Biol       Date:  2011-12-02

Review 6.  Contribution of immunomodulators to gastroesophageal reflux disease and its complications: stromal cells, interleukin 4, and adiponectin.

Authors:  Jing Li; Xiaoxin Luke Chen; Anisa Shaker; Tadayuki Oshima; Jing Shan; Hiroto Miwa; Cheng Feng; Jun Zhang
Journal:  Ann N Y Acad Sci       Date:  2016-07-21       Impact factor: 5.691

7.  FGFR2 regulation by picrasidine Q inhibits the cell growth and induces apoptosis in esophageal squamous cell carcinoma.

Authors:  Yuanyuan Shi; Xuejiao Liu; Mangaladoss Fredimoses; Mengqiu Song; Hanyong Chen; Kangdong Liu; Mee-Hyun Lee; Zigang Dong
Journal:  J Cell Biochem       Date:  2017-10-27       Impact factor: 4.429

8.  Metabolic alterations in lung cancer-associated fibroblasts correlated with increased glycolytic metabolism of the tumor.

Authors:  Virendra K Chaudhri; Gregory G Salzler; Salihah A Dick; Melanie S Buckman; Raffaella Sordella; Edward D Karoly; Robert Mohney; Brendon M Stiles; Olivier Elemento; Nasser K Altorki; Timothy E McGraw
Journal:  Mol Cancer Res       Date:  2013-03-08       Impact factor: 5.852

9.  Localization of indoleamine 2,3-dioxygenase in human esophageal squamous cell carcinomas.

Authors:  Jinzhong Liu; Gaofeng Lu; Fuai Tang; Yiqing Liu; Guanglin Cui
Journal:  Virchows Arch       Date:  2009-10-21       Impact factor: 4.064

Review 10.  Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression.

Authors:  Masayuki Shimoda; Kieran T Mellody; Akira Orimo
Journal:  Semin Cell Dev Biol       Date:  2009-10-24       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.